PROCEPT BIOROBOTICS CORP's ticker is and the CUSIP is 74276L105. A total of 202 filers reported holding PROCEPT BIOROBOTICS CORP in Q2 2024. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $58,544,624 | -77.8% | 958,334 | -82.0% | 87.55% | -8.4% |
| Q1 2024 | $263,352,607 | +17.9% | 5,328,867 | 0.0% | 95.58% | -1.7% |
| Q4 2023 | $223,332,816 | +27.7% | 5,328,867 | 0.0% | 97.26% | +1.7% |
| Q3 2023 | $174,840,126 | -7.2% | 5,328,867 | 0.0% | 95.60% | +153.0% |
| Q2 2023 | $188,375,448 | +24.5% | 5,328,867 | 0.0% | 37.79% | +23.8% |
| Q1 2023 | $151,339,823 | -31.6% | 5,328,867 | 0.0% | 30.53% | -45.1% |
| Q4 2022 | $221,361,135 | -41.0% | 5,328,867 | -41.2% | 55.58% | -24.5% |
| Q3 2022 | $375,434,000 | +5.2% | 9,055,341 | -17.1% | 73.64% | +2.7% |
| Q2 2022 | $356,922,000 | -6.6% | 10,918,393 | 0.0% | 71.70% | +11.9% |
| Q1 2022 | $382,035,000 | +36.1% | 10,918,393 | -2.7% | 64.08% | +23.8% |
| Q4 2021 | $280,679,000 | -34.4% | 11,222,662 | 0.0% | 51.76% | +9.6% |
| Q3 2021 | $428,145,000 | – | 11,222,662 | – | 47.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 958,334 | $58,544,624 | 87.55% |
| JOHNSON & JOHNSON | 357,939 | $21,866,494 | 5.46% |
| Evolutionary Tree Capital Management, LLC | 66,239 | $4,046,541 | 4.16% |
| TRANSATLANTIQUE PRIVATE WEALTH LLC | 150,000 | $9,163,500 | 3.74% |
| Robocap Asset Management Ltd | 93,582 | $5,716,924 | 3.56% |
| Eagle Health Investments LP | 257,089 | $15,705,567 | 2.75% |
| Rhenman & Partners Asset Management AB | 440,000 | $26,879,600 | 2.58% |
| Taylor Frigon Capital Management LLC | 81,880 | $5,002,049 | 2.38% |
| KRS Capital Management, LLC | 46,105 | $2,816,554 | 2.11% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 762,694 | $46,592,976 | 1.78% |